PCM
EVH icon

Prelude Capital Management’s Evolent Health EVH Stock Holding History

Prelude Capital Management’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-16,420
Closed -$139K – 1372
2025
Q3 		$139K Buy
+16,420
New +$159K 0.01% 1012
2025
Q2 		– Sell
-24,490
Closed -$232K – 1103
2025
Q1 		$232K Buy
+24,490
New +$247K 0.02% 838
2020
Q4 		– Sell
-400
Closed -$5K – 1482
2020
Q3 		$5K Buy
+400
New +$4.7K ﹤0.01% 1557
2019
Q1 		– Sell
-317
Closed -$6K – 1870
2018
Q4 		$6K Buy
+317
New +$7.33K ﹤0.01% 1531

Other funds holding EVH

CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
RF
Rubicon Founders Nashville, Tennessee $138M AUM 61.96% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Prelude Capital Management's EVH Position: Q4 2025 in Review

Prelude Capital Management sold out of Evolent Health (EVH) in Q4 2025, closing a stake of 16,420 shares — an estimated $139K sold.

Prelude Capital Management first reported a position in EVH in Q4 2018 and held it in 4 quarters. The position peaked at $232K in Q1 2025. 215 funds tracked by Wall St. Rank hold EVH as of Q4 2025.

  • Prelude Capital Management reported no remaining Evolent Health position as of Q4 2025 after selling out during the quarter.
  • Prelude Capital Management sold 16,420 Evolent Health shares in Q4 2025, an estimated $139K.
  • Prelude Capital Management first reported a position in Evolent Health in Q4 2018 and held it in 4 quarters.
  • Prelude Capital Management's Evolent Health position peaked at $232K in Q1 2025.
  • 215 funds tracked by Wall St. Rank held Evolent Health as of Q4 2025.

Based on Prelude Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.